Health
Promoted content
Are you ready to play Digital Health Golf?
With the publication of the European Commission’s Communication on Digital Health in April, the course for digital health has been set – now it’s time to play Digital Health Golf!Promoted content
Cancer biomarkers in the era of personalised medicine
Cancer biomarkers are molecules that can be detected in bodily fluids or tissues. Cancer biomarkers can identify people who have cancer or who are at risk of getting cancer.
Lifecourse vaccination in Europe: Influenza prevention
Adult vaccination has been given less prominence than other health priorities. But given our ageing population, the problem of vaccine-preventable diseases and related complications in adults and elderly is likely to grow. Vaccinating these groups would allow them to stay...Promoted content
FEDIOL perspective – Hydrogenation in the context of the debate on Trans Fatty Acids (TFA)
FEDIOL supports the introduction of an EU-wide 2% non-ruminant TFA legal limit on fat basis in products intended to the final consumers together with the deletion of the existing full/partial hydrogenation labelling as prescribed by Regulation (EU) No 1169/2011.Promoted content
Place your bets: FTI Consulting’s EMA relocation game
The EU vote on 20 November will decide the new location of the European Medicines Agency (EMA), one of the big Brexit prizes.Promoted content
Increasing access to medicines: Better care for more patients
Due to austerity measures and weak growth, our ageing populations and rising healthcare costs driven by new, expensive treatments, European healthcare faces unprecedented and growing pressures.Promoted content
Soft drinks industry to reduce added sugars a further 10% by 2020
The European soft drinks industry has been on a sugar reduction journey since the 1970's and the introduction of the first no calorie drinks.Promoted content
INFOGRAPHIC: Rare diseases in the EU
Rare diseases affect more than 30 million Europeans, many of whom are children! What is the European Union doing about it?Promoted content
INFOGRAPHIC: Call to action on Familial Hypercholesterolemia (FH)
MEPs and patient organisations call EU to action on Familial Hypercholesterolemia (FH), a genetic disease characterised by high levels of the 'bad' cholesterol in the patients.Promoted content
INFOGRAPHIC: Knowledge of cardiovascular disease in the European Parliament
Knowledge of cardiovascular disease among members of the European Parliament is fairly low, according to a survey by ComRes.Promoted content
Significant and Enduring Burden of Cardiovascular Disease in Europe
Cardiovascular disease (CVD) is the leading cause of death among women and men in Europe, causing over 4.35 million deaths each year in the 53 member states of the World Health Organization European Region and more than 1.9 million deaths each year in the European UnionSpecial ReportPromoted content
Getting Europe Moving
A new study shows the costs of ‘doing nothing’: the inactivity time bomb is killing 500,000 Europeans, and costing over € 80 billion per year. ISCA (International Sport & Culture Association) is campaignin to get 100 million Europeans to move more by 2020. Read the full report and find out what you can do to help get Europe moving at http://inactivity-time-bomb.nowwemove.com.Promoted content
Familial Hypercholesterolemia
What is FH? FH is an inherited condition associated with high “bad” cholesterol (low-density lipoprotein-cholesterol or LDL-C) and may predispose a person to premature cardiovascular disease (CVD). People with FH are unable to process the body’s natural supply of cholesterol, leading to very high levels of “bad” cholesterol that can block arteries and lead to a heart attack or stroke.Special ReportPromoted content
INFOGRAPHIC: Vaccine R&D leaders
Vaccination may be the most effective public health intervention of all time. This is especially true in developing countries, where many families can’t find or afford health care when they get sick. The prevention offered by vaccines can be life-saving.Promoted content
Europe’s Cancer Challenge
Cancer is the second most common cause of death in the European Union. New approaches are urgently needed to address the growing number of cancer cases diagnosed each year.Promoted content
INFOGRAPHIC: Europe losing the battle against diabetes
56 million in Europe have diabetes. By 2035, this number is expected to grow to nearly 70 million, underlining shortcomings of existing policies to fight the disease.Promoted content
INFOGRAPHIC: Europe has the highest prevalence of high cholesterol in the world
133 million suffer from so-called "bad cholesterol" in the In the EU's five biggest countries - Germany, France, Italy, Spain and the UK -, according to the World Health Organisation (WHO). Overall, Europe is the continent with the highest prevalence of the chronic disease, latest statistics show.Promoted content
Investing in the future of health
In a bid to highlight the important yet highly delicate nature of Europe’s innovative industries, a new report, produced by the Deloitte Health Economics Group and commissioned by Janssen, has sought to evaluate the comparable risks incurred across five major industries.Promoted content
